ESG

Strategic Resources navigates a key environmental review for its iron ore pellet plant, tapping into Quebec's hydro power for the global green steel market.

As Evolus presents at a key healthcare conference, investors watch to see if its new filler line and digital strategy can deliver on bold promises.

After a breakout first year, Maine's sustainable canned water brand is expanding into Boston and Florida, leveraging its pure origins and a veteran sales team.

P4ML joins the Orphan Therapeutics Accelerator to bring shelved cures to patients, leveraging a new non-profit model and expanding access to the MENA region.

With a key gene therapy approval imminent and major clinical data on deck, REGENXBIO's upcoming financial report will be a crucial test for the biotech.

Flush with cash and nearing major clinical milestones for its neuromuscular disease pipeline, Dyne Therapeutics is set to make its case to investors.

As Aura presents its precision oncology pipeline at key conferences, investors will weigh the promise of its lead drug against a challenging financial landscape.

With its new HAE drug EKTERLY® smashing revenue forecasts, KalVista heads to key conferences where investors will scrutinize its path to profitability.

Rise Wellness launches its new 30g carbonated protein drink at Costco, betting on fizz and function to capture a rapidly growing, competitive market.

With its stock lagging, TScan Therapeutics will use a key conference to highlight upcoming clinical trial data and convince investors of its pipeline's value.

With an $11.75M boost, a new device promises blood results in minutes, not hours, signaling a major pharma player's strategic pivot into diagnostics.

A landmark partnership aims to bring precision cancer therapy, or Theranostics, to millions in underserved nations, backed by a major WHO resolution.

A new partnership will integrate 150 million medical images into Verily's AI platform, aiming to accelerate health research and democratize discovery.

A new partnership between Salience Labs and Tower Semiconductor aims to mass-produce optical switches, a critical technology for faster, greener AI data centers.

The private aviation operator has secured the FAA Diamond Award, signaling a new benchmark in aircraft safety and technician training for the industry.

As global ESG rules become a complex web, Datamaran's new AI platform aims to help firms move from reactive compliance to proactive corporate strategy.

The Swedish health firm reports a 51% revenue surge and record profits, fueled by a string of strategic acquisitions aimed at dominating the Americas.

Appliance giant Groupe SEB faces a 25% profit drop, launching a massive AI-driven savings plan. Can it navigate global headwinds and job cuts?

The certification giant posts 6.5% organic growth, rewarding investors while doubling down on sustainability, renewables, and cybersecurity acquisitions.

With a new CEO at the helm and a pivotal trial for its lead drug on the horizon, all eyes are on PureTech's upcoming investor conference presentation.